Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action".
作者信息
Abdelmaksoud Ayman, Goldust Mohamad, Vestita Michelangelo
机构信息
Mansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.
Department of Dermatology, University of Rome G. Marconi, Rome, Italy.
出版信息
Dermatol Ther. 2020 Jul;33(4):e13360. doi: 10.1111/dth.13360. Epub 2020 Apr 16.
Abstract
摘要
相似文献
1
Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action".关于《COVID-19与银屑病：是时候限制免疫抑制剂治疗了吗？行动呼吁》的评论
Dermatol Ther. 2020 Jul;33(4):e13360. doi: 10.1111/dth.13360. Epub 2020 Apr 16.
2
Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days.银屑病和银屑病关节炎：在新冠疫情期间如何管理免疫抑制剂
Dermatol Ther. 2020 Jul;33(4):e13415. doi: 10.1111/dth.13415. Epub 2020 May 2.
3
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.新型冠状病毒肺炎与银屑病：是时候限制免疫抑制剂的使用了吗？呼吁采取行动。
Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22.
4
Comment on "Antipsoriatic treatments during COVID-19 outbreak".关于“新冠肺炎疫情期间的银屑病治疗”的评论
Dermatol Ther. 2020 Jul;33(4):e13491. doi: 10.1111/dth.13491. Epub 2020 Jun 12.
5
Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits.2019冠状病毒病疫情期间银屑病的生物治疗：选择需权衡风险与获益。
Dermatol Ther. 2020 Jul;33(4):e13490. doi: 10.1111/dth.13490. Epub 2020 May 20.
6
A challenging case of psoriasis flare-up after COVID-19 infection.1例新型冠状病毒肺炎感染后银屑病病情加重的疑难病例。
J Dermatolog Treat. 2020 Aug;31(5):448-449. doi: 10.1080/09546634.2020.1764904. Epub 2020 May 15.
7
Biologics for psoriasis in COVID-19 era: What do we know?新冠疫情时代用于治疗银屑病的生物制剂：我们了解什么？
Dermatol Ther. 2020 Jul;33(4):e13467. doi: 10.1111/dth.13467. Epub 2020 Jun 15.
8
COVID-19 in an elderly patient treated with secukinumab.一位接受司库奇尤单抗治疗的老年患者的新型冠状病毒肺炎
Dermatol Ther. 2020 Jul;33(4):e13580. doi: 10.1111/dth.13580. Epub 2020 May 27.
9
Antipsoriatic treatments during COVID-19 outbreak.新冠疫情期间的银屑病治疗
Dermatol Ther. 2020 Jul;33(4):e13345. doi: 10.1111/dth.13345. Epub 2020 Apr 10.
10
Biologic therapy for psoriasis during the covid-19 outbreak is not a choice.在新冠疫情期间，银屑病的生物治疗并非一种选择。
J Dermatolog Treat. 2020 Jun;31(4):320-321. doi: 10.1080/09546634.2020.1749545. Epub 2020 Apr 6.
引用本文的文献
1
Use of biologics in patients with psoriasis - A retrospective analysis based on real-world data.生物制剂在银屑病患者中的应用——基于真实世界数据的回顾性分析。
Skin Res Technol. 2024 Jan;30(1):e13550. doi: 10.1111/srt.13550.
2
The Relationship Between Psoriasis, COVID-19 Infection and Vaccination During Treatment of Patients.银屑病、COVID-19 感染与治疗期间疫苗接种的关系。
Adv Exp Med Biol. 2023;1412:339-355. doi: 10.1007/978-3-031-28012-2_18.
3
Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: studies.了解半乳糖凝集素抑制剂作为严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白潜在候选物的作用：研究。
RSC Adv. 2020 Aug 13;10(50):29873-29884. doi: 10.1039/d0ra04795c. eCollection 2020 Aug 10.
4
Biologics for Psoriasis During the COVID-19 Pandemic.新冠疫情期间用于治疗银屑病的生物制剂
Front Med (Lausanne). 2021 Dec 6;8:759568. doi: 10.3389/fmed.2021.759568. eCollection 2021.
5
Biologics for Psoriasis during the COVID-19 Pandemic.新冠疫情期间用于治疗银屑病的生物制剂
J Clin Med. 2021 Mar 30;10(7):1390. doi: 10.3390/jcm10071390.
6
The impact of COVID-19 in patients with psoriasis: A multicenter study in Istanbul.COVID-19 对银屑病患者的影响：伊斯坦布尔的一项多中心研究。
Dermatol Ther. 2021 Jan;34(1):e14691. doi: 10.1111/dth.14691. Epub 2020 Dec 30.
7
Generalized pustular psoriasis following COVID-19.新冠病毒感染后泛发性脓疱型银屑病
Dermatol Ther. 2021 Jan;34(1):e14595. doi: 10.1111/dth.14595. Epub 2020 Dec 3.
8
Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.COVID-19 大流行中的皮肤表现和注意事项：系统评价。
Dermatol Ther. 2020 Nov;33(6):e13986. doi: 10.1111/dth.13986. Epub 2020 Aug 6.
9
COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain.西班牙北部接受生物免疫抑制剂治疗的 COVID-19 合并银屑病和银屑病关节炎患者与接受阿普米司特治疗患者的比较。
Dermatol Ther. 2020 Nov;33(6):e13961. doi: 10.1111/dth.13961. Epub 2020 Jul 27.
10
COVID-19 and dermatology: a comprehensive guide for dermatologists.新型冠状病毒肺炎与皮肤病学：皮肤科医生实用指南。
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):1388-1394. doi: 10.1111/jdv.16545. Epub 2020 Jun 10.
本文引用的文献
1
Dermatology staff participate in fight against Covid-19 in China.中国皮肤科医护人员参与抗击新冠疫情。
J Eur Acad Dermatol Venereol. 2020 May;34(5):e210-e211. doi: 10.1111/jdv.16390.
2
Should biologics for psoriasis be interrupted in the era of COVID-19?在新冠疫情时代，银屑病生物制剂是否应中断使用？
J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.
3
No association between whole-body ultraviolet A1 phototherapy and skin cancers in humans: a cancer registry linkage study.
Br J Dermatol. 2020 Sep;183(3):586-587. doi: 10.1111/bjd.19041. Epub 2020 May 26.
4
Should patients stop their biologic treatment during the COVID-19 pandemic.在新冠疫情期间，患者是否应该停止生物制剂治疗？
J Dermatolog Treat. 2020 Jun;31(4):317-318. doi: 10.1080/09546634.2020.1742438. Epub 2020 Mar 19.
5
Challenges and Countermeasures of Integrative Cancer Therapy in the Epidemic of COVID-19.新冠疫情下癌症综合治疗面临的挑战与对策
Integr Cancer Ther. 2020 Jan-Dec;19:1534735420912811. doi: 10.1177/1534735420912811.
6
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.新型冠状病毒（COVID-19）感染中枢神经系统的证据：组织分布、宿主-病毒相互作用及潜在神经嗜性机制。
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998. doi: 10.1021/acschemneuro.0c00122. Epub 2020 Mar 13.
7
Older adults on systemic treatment for psoriasis and risk of infection: a propensity score-matched population-based study.接受银屑病系统治疗的老年人与感染风险：一项倾向评分匹配的基于人群的研究。
Br J Dermatol. 2020 Sep;183(3):564-566. doi: 10.1111/bjd.19028. Epub 2020 May 15.
8
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.新型冠状病毒肺炎与银屑病：是时候限制免疫抑制剂的使用了吗？呼吁采取行动。
Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22.
9
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.抗 HCV，核苷酸抑制剂，重新用于 COVID-19。
Life Sci. 2020 May 1;248:117477. doi: 10.1016/j.lfs.2020.117477. Epub 2020 Feb 28.
10
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.SARS-CoV2 的神经侵袭性可能在 COVID-19 患者的呼吸衰竭中起作用。
J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
Zotero 插件